MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomizedTommaso De Pas,Joo-Hang Kim,Konstantinos Zarogoulidis,Marcin Zieliński,Jubrail Dahabreh,Tonu Vanakesa, Arnd Nush,Emilio Esteban González,Hans Hoffman,Sumitra Thongprasert,Muriel Debois,Jean-Yves Douillard,Nasser K. Altorki,Channa Debruyne,Johan VansteenkisteJOURNAL OF THORACIC ONCOLOGY（2009）引用 23|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
